Publication | Closed Access

Blocking PD-1/PD-L1 by an ADCC enhanced anti-B7-H3/PD-1 fusion protein engages immune activation and cytotoxicity

Anti-b7-h3/pd-1 Fusion ProteinAutoimmune DiseaseImmune ActivationImmunologyTumor ImmunityCell DeathImmunologic MechanismImmune SurveillanceAutoimmunityImmune Checkpoint InhibitorImmunotherapyMedicineCell Biology